Elicio Therapeutics (ELTX) Gross Profit (2020 - 2021)
Elicio Therapeutics' (ELTX) quarterly Gross Profit came in at $25.5 million in Q4 2021, up 7560.06% YoY from $333000.0 in Q4 2020, and up 1647.12% on a QoQ basis from $1.5 million in Q3 2021.
Elicio Therapeutics (ELTX) Gross Profit (2020 - 2021) Analysis & Trends
Elicio Therapeutics (ELTX) has 2 years of Gross Profit data on file, last reported at $25.5 million in Q4 2021.
- Quarterly Gross Profit rose 7560.06% year-over-year to $25.5 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $27.9 million (up 3279.27% YoY) and the FY2022 annual result came in at $2.3 million, down 91.75% from the prior year.
- Gross Profit climbed to $25.5 million in Q4 2021, from $1.5 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $25.5 million in Q4 2021 to a low of -$383000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Elicio Therapeutics | 58.41 Mn | 34.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 25.51 Mn |
| Dec 31, 2021 | 25.51 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 540,000.00 |
| Jun 30, 2021 | 540,000.00 |
| Mar 31, 2021 | 371,000.00 |
| Mar 31, 2021 | 371,000.00 |
| Dec 31, 2020 | 333,000.00 |
| Dec 31, 2020 | 333,000.00 |
| Sep 30, 2020 | 479,000.00 |
| Sep 30, 2020 | 479,000.00 |
| Jun 30, 2020 | 396,000.00 |
| Jun 30, 2020 | 396,000.00 |
| Mar 31, 2020 | -383,000.00 |
| Mar 31, 2020 | -383,000.00 |